• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巴西一名患者体内亲内脏性黄热病疫苗变异株的特征分析。

Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.

作者信息

Engel Amber R, Vasconcelos Pedro F C, McArthur Monica A, Barrett Alan D T

机构信息

Department of Pathology, The University of Texas Medical Branch, Galveston, TX 77555-0609, USA.

出版信息

Vaccine. 2006 Apr 5;24(15):2803-9. doi: 10.1016/j.vaccine.2006.01.009. Epub 2006 Jan 18.

DOI:10.1016/j.vaccine.2006.01.009
PMID:16464518
Abstract

Although the live attenuated yellow fever (YF) 17D vaccine is considered to be one of the safest vaccines in the world today, several cases of disease associated with administration of the vaccine have been reported, including YF vaccine-associated viscerotropic disease (YF-VAVD), which was first described in 1996. All YF-VAVD isolates sequenced to date have shown very little genomic change when compared to their parental vaccine strains. In this study, we report the characterization of an isolate, BeH291597 (Brazil75), from a 1975 fatal case of YF-VAVD in Brazil. Comparison of Brazil75 with the genomic sequence of the parental 17DD vaccine strain revealed two amino acid substitutions (at positions M-49 and NS4B-240) that were unique to Brazil75. Although still a rare occurrence, this isolate suggests that YF-VAVD has been present much longer than previously recognized.

摘要

尽管减毒活黄热病(YF)17D疫苗被认为是当今世界上最安全的疫苗之一,但仍有几例与该疫苗接种相关的疾病报告,包括1996年首次描述的黄热病疫苗相关内脏型疾病(YF-VAVD)。迄今为止测序的所有YF-VAVD分离株与它们的亲代疫苗株相比,基因组变化都非常小。在本研究中,我们报告了一株来自1975年巴西YF-VAVD死亡病例的分离株BeH291597(Brazil75)的特征。将Brazil75与亲代17DD疫苗株的基因组序列进行比较,发现了两个氨基酸替换(位于M-49和NS4B-240位置),这是Brazil75所特有的。尽管仍然罕见,但该分离株表明YF-VAVD存在的时间比以前认为的要长得多。

相似文献

1
Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil.巴西一名患者体内亲内脏性黄热病疫苗变异株的特征分析。
Vaccine. 2006 Apr 5;24(15):2803-9. doi: 10.1016/j.vaccine.2006.01.009. Epub 2006 Jan 18.
2
Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus.与野生型黄热病毒的HeLa细胞减毒相关的分子和生物学变化。
Virology. 1999 Sep 1;261(2):309-18. doi: 10.1006/viro.1999.9873.
3
Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice.在小鼠中具有改变的神经毒力表型的黄热病毒抗原变异体。
Virology. 1997 Apr 14;230(2):376-80. doi: 10.1006/viro.1997.8496.
4
Pressure-inactivated yellow fever 17DD virus: implications for vaccine development.压力灭活的黄热病17DD病毒:对疫苗研发的启示
J Virol Methods. 2008 Jun;150(1-2):57-62. doi: 10.1016/j.jviromet.2008.03.002.
5
Production of yellow fever 17DD vaccine virus in primary culture of chicken embryo fibroblasts: yields, thermo and genetic stability, attenuation and immunogenicity.黄热病17DD疫苗病毒在鸡胚成纤维细胞原代培养中的生产:产量、热稳定性和遗传稳定性、减毒及免疫原性。
Vaccine. 2005 Mar 31;23(19):2501-12. doi: 10.1016/j.vaccine.2004.10.035.
6
Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.一种非致死性、嗜仓鼠内脏的黄热病毒株的表型和分子特征
Virus Res. 2005 Jun;110(1-2):65-71. doi: 10.1016/j.virusres.2005.01.004.
7
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.17DD和世界卫生组织17D-213/77黄热病疫苗在儿童中的免疫原性和反应原性的随机、双盲、多中心研究:对巴西国家免疫规划的影响
Vaccine. 2007 Apr 20;25(16):3118-23. doi: 10.1016/j.vaccine.2007.01.053. Epub 2007 Jan 22.
8
Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it.黄热病毒法国内脏嗜性野生型毒株与源自该毒株的减毒活疫苗株法国嗜神经病毒疫苗包膜蛋白基因的核苷酸序列及推导的氨基酸序列比较
Virology. 1993 Feb;192(2):692-5. doi: 10.1006/viro.1993.1090.
9
Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice.17D - 204疫苗亚株特异性包膜蛋白表位的突变改变了黄热病病毒在小鼠体内的发病机制。
Virology. 1998 Apr 25;244(1):59-65. doi: 10.1006/viro.1998.9057.
10
Yellow fever vaccine-associated viscerotropic disease and death in Spain.西班牙的黄热病疫苗相关嗜内脏性疾病及死亡
J Clin Virol. 2006 Jun;36(2):156-8. doi: 10.1016/j.jcv.2006.02.005. Epub 2006 Apr 4.

引用本文的文献

1
A Yellow Fever Virus 17D Infection and Disease Mouse Model Used to Evaluate a Chimeric Binjari-Yellow Fever Virus Vaccine.一种用于评估嵌合宾贾里-黄热病病毒疫苗的黄热病病毒17D感染与疾病小鼠模型。
Vaccines (Basel). 2020 Jul 9;8(3):368. doi: 10.3390/vaccines8030368.
2
Severe Multiorgan Failure Following Yellow Fever Vaccination.黄热病疫苗接种后发生的严重多器官功能衰竭。
Vaccines (Basel). 2020 May 26;8(2):249. doi: 10.3390/vaccines8020249.
3
Yellow fever vaccine and risk of developing serious adverse events: a systematic review.黄热病疫苗与发生严重不良事件的风险:一项系统综述
Rev Panam Salud Publica. 2018 Jun 5;42:e75. doi: 10.26633/RPSP.2018.75. eCollection 2018.
4
Gamma-interferon exerts a critical early restriction on replication and dissemination of yellow fever virus vaccine strain 17D-204.γ干扰素对黄热病病毒疫苗株17D - 204的复制和传播发挥关键的早期限制作用。
NPJ Vaccines. 2018 Jan 23;3:5. doi: 10.1038/s41541-017-0039-z. eCollection 2018.
5
Yellow fever vaccine-associated viscerotropic disease: current perspectives.黄热病疫苗相关内脏嗜性疾病:当前观点
Drug Des Devel Ther. 2016 Oct 12;10:3345-3353. doi: 10.2147/DDDT.S99600. eCollection 2016.
6
Questions regarding the safety and duration of immunity following live yellow fever vaccination.关于黄热病活疫苗接种后的安全性和免疫持续时间的问题。
Expert Rev Vaccines. 2016 Dec;15(12):1519-1533. doi: 10.1080/14760584.2016.1198259. Epub 2016 Jun 20.
7
A humanized IgG but not IgM antibody is effective in prophylaxis and therapy of yellow fever infection in an AG129/17D-204 peripheral challenge mouse model.一种人源化 IgG 抗体而非 IgM 抗体在 AG129/17D-204 外周挑战小鼠模型中对黄热病感染的预防和治疗有效。
Antiviral Res. 2012 Apr;94(1):1-8. doi: 10.1016/j.antiviral.2012.02.001. Epub 2012 Feb 15.
8
Yellow fever virus vaccine-associated deaths in young women.黄热病病毒疫苗相关的年轻女性死亡病例。
Emerg Infect Dis. 2011 Oct;17(10):1891-3. doi: 10.3201/eid1710.101789.
9
WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13-14 May 2009.世界卫生组织制造和评估黄热病疫苗技术规格工作组会议报告,瑞士日内瓦,2009 年 5 月 13-14 日。
Vaccine. 2010 Dec 6;28(52):8236-45. doi: 10.1016/j.vaccine.2010.10.070. Epub 2010 Nov 4.
10
NIAID workshop on Flavivirus immunity.NIAID 关于黄病毒免疫的研讨会。
Viral Immunol. 2010 Jun;23(3):235-40. doi: 10.1089/vim.2009.0114.